A 39-year-old woman diagnosed with Stage IV adenocarcinoma of the left lung, negative for EGFR, ALK, and ROS-1, but with an ERBB2 mutation, experienced neurological symptoms leading to a diagnosis of brain metastasis in 2019. This evidence concerns the gene ERBB2 and adenocarcinoma.